ArticleEuropean journal of nuclear medicine and molecular imaging2016
Malignant lipogenesis defined by
Article in European journal of nuclear medicine and molecular imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- The grade of individual prostate cancer lesions predicted by magnetic resonance imaging and positron emission tomography.Communications medicine · 2023Article
- Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?Cancer research · 2021Review
- Salvage Pelvic Lymph Node Dissection and Current State of Imaging for Recurrent Prostate Cancer: Does a Standard Exist?Current urology reports · 2020Review
- FABP5 as a novel molecular target in prostate cancer.Drug discovery today · 2020Review
- Comparison ofScientific reports · 2020Article
- Carbon Flux as a Measure of Prostate Cancer Aggressiveness: [International journal of medical sciences · 2020Article
- Imaging Metabolically Active Fat: A Literature Review and Mechanistic Insights.International journal of molecular sciences · 2019Review
- Molecular imaging of prostate cancer.The British journal of radiology · 2018Review
- Repeatability of quantitative parameters of 18F-fluoride PET/CT and biochemical tumour and specific bone remodelling markers in prostate cancer bone metastases.EJNMMI research · 2017Article
- The value of [European journal of nuclear medicine and molecular imaging · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeMalignant de novo lipogenesis is strongly linked to the aggressiveness of prostate cancer (PCa) under experimental conditions.
methodsAll patients undergoing
resultsA total of 121 patients were included, and 22 PCa-specific deaths were recorded. The mean PSA level at the time of PET was 2.69 ± 4.35 ng/mL. The median follow-up of the study population was 79 ± 28 months. PET identified at least one PCa lesion in 53 % of patients. Five-year PCa-specific survival after PET was 80 % and 100 % in patients with a positive and a negative PET scan, respectively (p < 0.001). Time-to-death was linearly correlated with highest SUV
conclusionMalignant
Indexed as
Identifiers
27392615What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.